Table 1 |
|||||
|
Treatment groups and sample sizes for experiments 1, 2 and 3 |
|||||
|
Nr mice exp 1 |
Nr mice exp 2 |
||||
|
Days |
Dose |
CWavir |
CWvir |
CWavir |
CWvir |
|
|
|||||
|
4 |
0 |
5 |
5* |
4 |
4# |
|
4 |
1 |
5 |
5** |
4 |
4 |
|
4 |
3 |
5 |
5 |
4 |
4 |
|
4 |
5 |
5 |
5§ |
4 |
4 |
|
Nr mice exp 3 |
|||||
|
Days |
Dose |
CWavir |
CWvir |
||
|
|
|||||
|
1 |
0 |
4 |
4 |
||
|
1 |
4 |
4 |
4 |
||
|
1 |
8 |
4 |
4 |
||
|
1 |
12 |
4 |
4 |
||
|
1 |
20 |
4 |
4 |
||
|
|
|||||
|
Days: duration of pyrimethamine treatment in days, starting from day 5 after infection. Dose: mg/kg/day. Nr mice: sample sizes for each group, with sample sizes for each experiment. * Each symbol indicates a mouse excluded from analysis, euthanized early in the experiment because of severe anaemia. § 1 mouse excluded, no parasites detected at time of treatment. # 4 mice euthanized on d11 and d12 after infection, data have been used where possible. |
|||||
|
Schneider et al. Malaria Journal 2008 7:257 doi:10.1186/1475-2875-7-257 |
|||||